You are here: Industry Insights > variant

News List

Pfizer COVID-19 vaccine works against Brazil variant in lab study expresspharma
March 09, 2021
The scientists said the neutralising ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.
Will fast-track vaccines for coronavirus variants: UK MHRA expresspharma
March 05, 2021
The accelerated process is based on that used for seasonal flu vaccines each year, said MHRA.
EMA issues its requirements for adapting COVID-19 vaccines for viral variants europeanpharmaceuticalreview
March 01, 2021
The European Medicines Agency has set out its guidelines for vaccine manufacturers adapting their approved COVID-19 vaccines to combat viral variants.
FDA updates Covid-19 variant guidance for vaccines and therapies pharmaceutical-technology
February 25, 2021
US healthcare regulator the Food and Drug Administration (FDA) has updated its guidance to help vaccine and therapeutics companies to address the emergence of new variants of SARS-CoV-2, the virus that causes Covid-19.
Celltrion develops neutralising antibody cocktail to tackle COVID-19 variant spread expresspharma
February 25, 2021
CT-P59 demonstrated neutralising capability against key emerging mutations, including the UK variant in addition to six variant genome mutations of SARS-CoV-2.
Zymo Launches COVID-19 Sequencing Service for Detection of Emerging SARS-CoV-2 Variants americanpharmaceuticalreview
February 24, 2021
Zymo Research announced their COVID-19 Variant Sequencing Service. This new global service expands Zymo Research's end-to-end SARS-CoV-2 solutions that include sample collection, RNA extraction, and SARS-CoV-2 detection.
Indian pharma companies say they can quickly rework vaccines to tackle COVID-19 variants expresspharma
February 24, 2021
India is the world’s biggest maker of vaccines, and its companies have promised to produce billions of doses of COVID-19 shots.
US FDA says trials of modified vaccines for COVID-19 variants could take months expresspharma
February 24, 2021
Acting FDA Commissioner Janet Woodcock said companies should not wait until a mutated virus is demonstrated to be able to escape the vaccines to begin developing new versions.
FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants americanpharmaceuticalreview
February 23, 2021
The U.S. Food and Drug Administration (FDA) has issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2 ...
Could a nasal spray prevent coronavirus transmission? worldpharmanews
February 22, 2021
A nasal antiviral created by researchers at Columbia University Vagelos College of Physicians and Surgeons blocked transmission of SARS-CoV-2 in ferrets, suggesting the nasal spray also may prevent infection in people exposed to the new coronavirus ...

Previous page 1 2 3 4 5 6 7 Next page